Part 2/11:
Wood starts by emphasizing her conviction in the multiomics revolution, which she believes will be the most transformative application of AI over the next few years. She notes that her "Genomic Revolution" portfolio, which is focused on breakthroughs in genetics and biotech, has experienced substantial growth—up to a 6% compound annual growth rate, with recent momentum guided by deregulation.